In the Ozempic Era, China Readies a Home-Grown Obesity Drug
June 3, 2025 / mazdutide obesity drug / GLP-1 GCGR China / Innovent Biologics weight loss / dual agonist therapy / Chinese obesity treatment
China’s Innovent Biologics is nearing approval for mazdutide, a dual GLP-1/GCGR agonist that significantly reduces weight in obese patients. Clinical trial data support its efficacy and safety, positioning it as a promising next-generation obesity therapy.
Daily bean consumption linked to improved heart and metabolic health
June 3, 2025 / bean health benefits / prediabetes diet tips / cholesterol reduction beans / black beans inflammation / chickpeas heart health
A 12-week study found daily consumption of black beans or chickpeas improved cholesterol and reduced inflammation in adults with prediabetes, suggesting a simple dietary intervention may lower risks for heart disease and type 2 diabetes without affecting glucose levels.
Obesity can raise colorectal cancer risk by 30–50%, study finds
June 5, 2025 / obesity cancer risk / colorectal cancer prevention / central obesity CRC / weight loss cancer link / non-invasive CRC screening
Obesity—especially central obesity—raises colorectal cancer risk by 30–50% by promoting inflammation and metabolic dysfunction. Prevention efforts must combine weight management, dietary changes, and early screening, including non-invasive options like COLOTECT, to reduce cancer burden and improve patient outcomes.
Back-to-basics, ‘not fad’ diets beat heart disease and diabetes
June 4, 2025 / cardiometabolic health / insulin resistance diet / whole foods diabetes / heart disease nutrition / healthy lifestyle prevention
A comprehensive review confirms that balanced, whole-food diets—not restrictive fads—improve cardiometabolic health by lowering risks of obesity, diabetes, and cardiovascular disease. Fiber-rich carbohydrates, healthy fats, and plant-based proteins are key to reversing insulin resistance and preventing disease progression.
Combination of weight loss drugs may be better for pre-metabolic surgery patients than GLP-1s or dieting alone
June 3, 2024 / extreme obesity treatment / preoperative weight loss / metabolic surgery prep / GLP-1 alternatives / anti-obesity medications
For patients with BMI ≥70 preparing for metabolic surgery, multi-modal anti-obesity medications (mmAOMs) result in significantly greater preoperative weight loss than GLP-1s or diet alone, improving surgical safety and addressing a critical gap in extreme obesity management.
Experts review how 12-hour biological cycles operate in mice, with clues in humans
June 4, 2025 / ultradian rhythms / metabolic health / 12-hour cycles / XBP1 gene regulation / biological timing
Twelve-hour biological rhythms regulate metabolism, stress, and immune function in mice and humans. Disruption of these ultradian cycles is linked to diseases like obesity and schizophrenia, offering new potential for diagnostics and treatment in chronobiology-based medicine.
Meto Launches to Tackle the Metabolic Health Crisis with Insurance-First, Provider-Powered Care
June 4, 2025 / metabolic health / obesity care / insurance-first model / preventive medicine / digital health platform
Meto has launched an insurance-first, provider-powered platform for comprehensive metabolic, hormonal, and obesity care, aiming to overcome access and cost barriers while improving long-term outcomes through personalized, coordinated, and covered treatment plans.
Metsera to Present New Research Highlighting the Breadth and Momentum of its Next-Generation Obesity Portfolio at the 85th Scientific Sessions of the American Diabetes Association
June 5, 2025 / obesity treatment / metabolic disease / ADA 2025 / MET-097i data / next-generation therapies
Metsera will present new clinical and preclinical data on its next-generation obesity therapies, including lead candidate MET-097i, at the ADA 2025 Scientific Sessions, highlighting scalable, ultra-long acting treatment strategies for obesity and metabolic disease.
Less Cysteine Could Be the Key to Effortless Fat Loss
June 5, 2025 / cysteine restriction / fat browning / obesity treatment / metabolic health / amino acid metabolism
Yale researchers found that removing cysteine from the diet in obese mice triggered a transformation of white fat into calorie-burning brown fat, leading to rapid weight loss and metabolic improvements—offering a potential new therapeutic target for obesity and metabolic disease.
Rising liver disease cases demand immediate attention
June 6, 2024 / MASLD / liver disease / early screening / MASH diagnosis / metabolic health
Global experts warn that metabolic liver diseases like MASLD and MASH are underdiagnosed and rising rapidly. Early screening, AI diagnostics, and person-centered care are urgently needed to prevent progression to liver failure, cirrhosis, and escalating healthcare costs.
Study finds geographic link between dementia and cardiometabolic disease
June 3, 2025 / dementia prevention / cardiometabolic disease / geographic health disparities / Alzheimer’s risk factors / public health strategy
A new study links regional dementia rates to cardiometabolic diseases like hypertension, diabetes, and heart disease. The Southern U.S. shows highest overlap. Reducing these modifiable risk factors could significantly lower dementia incidence nationwide.
Eating this popular fruit daily may support postmenopausal heart and metabolic health
June 3, 2025 / postmenopausal health / mango heart benefits / cholesterol reduction diet / metabolic wellness women / menopause cardiovascular risk
Daily mango consumption significantly reduced blood pressure and cholesterol in postmenopausal women with obesity, suggesting potential cardiovascular and metabolic health benefits. The fruit may offer a simple dietary strategy to reduce heart disease risk during menopause.
Association between plasma proteomic dynamic changes and metabolic outcomes in patients undergoing bariatric surgery
June 5, 2025 / bariatric surgery outcomes / proteomic changes obesity / IGFBP-1 HAOX1 biomarkers / metabolic health liver / RYGB VSG inflammation
Bariatric surgery induces significant, time-dependent changes in liver-expressed and inflammatory proteins, including IGFBP-1/2 and HAOX1, correlating with improved liver function and metabolic outcomes. Distinct proteomic responses vary by surgery type and obesity severity.
Healthy diet improves metabolism even without weight loss
June 6, 2025 / healthy diet metabolism / weight loss resistance / visceral fat reduction / HDL cholesterol leptin / cardiometabolic health benefits
A healthy diet significantly improves metabolic markers—such as HDL cholesterol, leptin levels, and visceral fat—even without weight loss, underscoring that metabolic health benefits can occur independently of body weight changes and may be biologically influenced.
Genetic and physiological insights into satiation variability predict responses to obesity treatment
June 6, 2025 / satiation variability obesity / genetic risk score weight loss / personalized obesity treatment / phentermine-topiramate response / liraglutide efficacy prediction
Researchers identified that individual differences in satiation, influenced by genetics and physiology, can predict responses to obesity treatments. A genetic risk score (CTSGRS) helps match patients to medications like phentermine-topiramate or liraglutide for optimal weight loss outcomes.
Experts share the most important thing(s) in the management of metabolic conditions
June 6, 2025 / metabolic disorders treatment / obesity insulin resistance / thyroid metabolism management / genetic metabolic conditions / lifestyle interventions metabolic health
Effective management of metabolic conditions requires understanding their root causes—ranging from genetics to lifestyle—and using a holistic approach that combines diet, exercise, medication, and emerging therapies to prevent complications like diabetes, obesity, and thyroid dysfunction.
Scientists call for more efforts to diagnose liver disease MASH
June 9, 2025 / MASH liver disease diagnosis / metabolic liver disease screening / early detection fatty liver / AI liver health tools / person-centered liver care
Global experts urge improved early diagnosis of MASH, a severe fatty liver disease, using expanded screening, AI tools, and person-centered care to prevent advanced liver damage. Early intervention could significantly reduce public health and economic burdens by 2030.
Rising liver disease cases demand immediate attention
June 6, 2025 / MASLD / liver disease screening / MASH diagnosis tools / metabolic liver health / early detection hepatology
Global health experts warn that early detection and integrated care for MASLD and MASH are urgently needed to curb rising liver disease cases. Calls for screening, AI diagnostics, and person-centered approaches aim to reduce mortality and healthcare burden by 2030.
Metabolic Dysfunction-Associated Steatohepatitis: The Global Epidemic Fueling a New Era in Liver Disease Innovation
June 6, 2025 / MASH treatment innovation / Rezdiffra FDA approval / liver fibrosis therapy / metabolic liver disease / global MASH epidemic
MASH, affecting nearly 500 million globally, has entered a new treatment era with the FDA approval of Rezdiffra. Despite this progress, underdiagnosis, late-stage detection, and access barriers persist, demanding urgent innovation in screening, treatment, and global health policy.
Clinical trial finds diabetes pill reduces liver scarring
June 6, 2025 / MASH treatment / dapagliflozin liver benefits / SGLT-2 inhibitor fibrosis / diabetes drug liver disease / liver inflammation clinical trial
Dapagliflozin, an SGLT-2 inhibitor used for type 2 diabetes, significantly reduced liver inflammation and fibrosis in MASH patients during a clinical trial, suggesting its potential as a dual-purpose treatment pending further research in broader populations.